Review



cell surface marker database  (Valeant Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Valeant Pharmaceuticals cell surface marker database
    <t>Cell</t> <t>surface</t> <t>marker</t> identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments
    Cell Surface Marker Database, supplied by Valeant Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell surface marker database/product/Valeant Pharmaceuticals
    Average 86 stars, based on 1 article reviews
    cell surface marker database - by Bioz Stars, 2026-05
    86/100 stars

    Images

    1) Product Images from "KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population"

    Article Title: KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population

    Journal: Journal of Cancer Research and Clinical Oncology

    doi: 10.1007/s00432-026-06450-8

    Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments
    Figure Legend Snippet: Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments

    Techniques Used: Marker, Expressing

    Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type
    Figure Legend Snippet: Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type

    Techniques Used: Marker, Biomarker Discovery, Staining, Fluorescence



    Similar Products

    cell surface marker database  (Valeant Pharmaceuticals)
    86
    Valeant Pharmaceuticals cell surface marker database
    <t>Cell</t> <t>surface</t> <t>marker</t> identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments
    Cell Surface Marker Database, supplied by Valeant Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell surface marker database/product/Valeant Pharmaceuticals
    Average 86 stars, based on 1 article reviews
    cell surface marker database - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population

    doi: 10.1007/s00432-026-06450-8

    Figure Lengend Snippet: Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments

    Article Snippet: We first identified all differentially expressed genes specific to each compartment, then cross-referenced these with a curated cell surface marker database (Bausch-Fluck et al. ), yielding 175 potential candidates across the three populations of interest (Fig. A).

    Techniques: Marker, Expressing

    Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population

    doi: 10.1007/s00432-026-06450-8

    Figure Lengend Snippet: Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type

    Article Snippet: We first identified all differentially expressed genes specific to each compartment, then cross-referenced these with a curated cell surface marker database (Bausch-Fluck et al. ), yielding 175 potential candidates across the three populations of interest (Fig. A).

    Techniques: Marker, Biomarker Discovery, Staining, Fluorescence